| pubmed-article:17295865 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17295865 | lifeskim:mentions | umls-concept:C0022271 | lld:lifeskim |
| pubmed-article:17295865 | lifeskim:mentions | umls-concept:C0020732 | lld:lifeskim |
| pubmed-article:17295865 | lifeskim:mentions | umls-concept:C0400914 | lld:lifeskim |
| pubmed-article:17295865 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17295865 | pubmed:dateCreated | 2007-2-13 | lld:pubmed |
| pubmed-article:17295865 | pubmed:abstractText | Acute hepatitis C virus infection in the era of universal screening of blood products has not disappeared, and is thought to be transmitted primarily via injecting drug use. A growing body of evidence supports iatrogenic transmission as an important mode of transmission. The aim of this study was to examine transmission routes and clinical characteristics in a group of patients with acute hepatitis C in Israel. | lld:pubmed |
| pubmed-article:17295865 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17295865 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17295865 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17295865 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17295865 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17295865 | pubmed:issn | 0815-9319 | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:OrenRanR | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:HalpernZamirZ | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:LurieYoavY | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:BaruchYaacovY | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:BlendisLauren... | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:VeitsmanEllaE | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:LandauDan-Avi... | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:Zelber-SagieS... | lld:pubmed |
| pubmed-article:17295865 | pubmed:author | pubmed-author:AckermannZviZ | lld:pubmed |
| pubmed-article:17295865 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17295865 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:17295865 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17295865 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17295865 | pubmed:pagination | 158-64 | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:meshHeading | pubmed-meshheading:17295865... | lld:pubmed |
| pubmed-article:17295865 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17295865 | pubmed:articleTitle | Acute hepatitis C in Israel: a predominantly iatrogenic disease? | lld:pubmed |
| pubmed-article:17295865 | pubmed:affiliation | Liver Disease Unit, Gastroenterology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. dr_lurie@tasmc.health.gov.il | lld:pubmed |
| pubmed-article:17295865 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17295865 | pubmed:publicationType | Multicenter Study | lld:pubmed |
